EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access

Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial

Philip A Petrou, Denise Cunningham, Katherine Shimel, Molly Harrington, Keri Hammel, Catherine A Cukras, Frederick L Ferris, Emily Y Chew, Wai T Wong

Investigative Ophthalmology & Visual Science · 13.01.2015 · 56 (1) · 330-338

DOI: 10.1167/iovs.14-15877 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Investigative Ophthalmology & Visual Science, online erschienen am 18.12.2014. Verfasst von Philip A Petrou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unit on Neuron-Glia Interactions in Retinal Diseases, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States. Die Arbeit wurde bisher 63-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAged, 80 and overDose-Response Relationship, DrugFemaleFluorescein AngiographyFollow-Up StudiesFundus OculiGeographic AtrophyHumansImmunosuppressive AgentsIntravitreal InjectionsMaleMiddle AgedPigment Epithelium of EyeProspective StudiesSirolimusTreatment OutcomeVisual Acuity

Stichwörter der Autor:innen

age-related macular degenerationclinical trialgeographic atrophysirolimus

Substanzen

Immunosuppressive AgentsSirolimus

Autor:innen und Institutionen

  • Unit on Neuron-Glia Interactions in Retinal Diseases, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • Office of the Clinical Director, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
  • The EMMES Corporation, Rockville, Maryland, United States.
  • Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Petrou, P. A., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., Chew, E. Y., & Wong, W. T. (2015). Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial. Investigative Ophthalmology & Visual Science, 56(1), 330-338. https://doi.org/10.1167/iovs.14-15877

Vancouver

Petrou PA, Cunningham D, Shimel K, Harrington M, Hammel K, Cukras CA, et al. Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial. Investigative Ophthalmology & Visual Science. 2015;56(1):330-338. doi:10.1167/iovs.14-15877

BibTeX
@article{Petrou2015,
  author = {Petrou, Philip A and Cunningham, Denise and Shimel, Katherine and Harrington, Molly and Hammel, Keri and Cukras, Catherine A and Ferris, Frederick L and Chew, Emily Y and Wong, Wai T},
  title = {Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2015},
  volume = {56},
  number = {1},
  pages = {330--338},
  doi = {10.1167/iovs.14-15877}
}
Kostenlos starten →